Adage Capital Partners GP L.L.C. Acquires 85,000 Shares of Health Catalyst, Inc. $HCAT

Adage Capital Partners GP L.L.C. grew its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 114.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 159,280 shares of the company's stock after purchasing an additional 85,000 shares during the period. Adage Capital Partners GP L.L.C. owned about 0.23% of Health Catalyst worth $722,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the business. First Light Asset Management LLC increased its holdings in shares of Health Catalyst by 99.1% in the 1st quarter. First Light Asset Management LLC now owns 10,436,807 shares of the company's stock valued at $47,279,000 after purchasing an additional 5,195,686 shares during the period. Cubist Systematic Strategies LLC increased its holdings in shares of Health Catalyst by 19.3% in the 1st quarter. Cubist Systematic Strategies LLC now owns 164,250 shares of the company's stock valued at $744,000 after purchasing an additional 26,580 shares during the period. Palogic Value Management L.P. increased its holdings in shares of Health Catalyst by 111.5% in the 1st quarter. Palogic Value Management L.P. now owns 676,900 shares of the company's stock valued at $3,066,000 after purchasing an additional 356,900 shares during the period. State of Wyoming increased its holdings in shares of Health Catalyst by 106.4% in the 1st quarter. State of Wyoming now owns 40,198 shares of the company's stock valued at $182,000 after purchasing an additional 20,721 shares during the period. Finally, Whetstone Capital Advisors LLC acquired a new position in shares of Health Catalyst in the 1st quarter valued at about $7,724,000. Institutional investors and hedge funds own 85.00% of the company's stock.

Health Catalyst Stock Performance

Health Catalyst stock traded down $0.10 during trading hours on Friday, reaching $3.15. 478,121 shares of the company were exchanged, compared to its average volume of 727,201. The firm has a market cap of $221.31 million, a price-to-earnings ratio of -2.08 and a beta of 1.53. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44. The stock has a 50-day moving average of $3.53 and a 200 day moving average of $3.88. Health Catalyst, Inc. has a 12 month low of $2.52 and a 12 month high of $9.24.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on HCAT shares. Citigroup downgraded Health Catalyst from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $6.50 to $3.50 in a report on Friday, August 8th. Cantor Fitzgerald restated a "neutral" rating and issued a $4.00 price objective (down previously from $9.00) on shares of Health Catalyst in a report on Friday, August 8th. Canaccord Genuity Group dropped their price objective on Health Catalyst from $9.00 to $5.00 and set a "buy" rating on the stock in a report on Friday, August 29th. Stifel Nicolaus dropped their price objective on Health Catalyst from $5.50 to $4.50 and set a "hold" rating on the stock in a report on Friday, August 8th. Finally, Summit Redstone set a $5.00 price objective on Health Catalyst in a report on Friday, August 29th. Three investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $4.73.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.